Department of Surgery, Division of Pediatric Surgery, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Department of Surgery, Division of Pediatric Surgery, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, PA.
J Pediatr Surg. 2020 Nov;55(11):2251-2259. doi: 10.1016/j.jpedsurg.2020.03.019. Epub 2020 Mar 31.
Minimally invasive nephrectomy is performed routinely for adult renal tumors and for many benign pediatric conditions. Although open radical nephroureterectomy remains the standard of care for Wilms tumor and most pediatric renal malignancies, there are an increasing number of reports of minimally invasive surgery (MIS) for those operations as well. The APSA Cancer Committee performed a systematic review to better understand the risks and benefits of MIS in pediatric patients with renal tumors.
The search focused on MIS for renal tumors in children and followed the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) checklist. The initial database search identified 491 published articles, and after progressive review of abstracts and full-length articles, 19 were included in this review.
There were two direct comparison studies where open surgery and MIS were compared. The remaining studies reported only on minimally invasive nephrectomy. Across all studies, there were a total of 151 patients, 126 of which had Wilms tumor and 10 patients had RCC. 104 patients had MIS, with 47 patients having open surgery. In the two studies in which open surgery and MIS were directly compared, more lymph nodes were harvested during open surgery (median = 2 (MIS) vs 5 (open); mean = 2.47 (MIS) vs 3.8 (open)). Many noncomparison studies reported the harvest of 2 of fewer lymph nodes for Wilms tumor. Several MIS patients were also noted to have intraoperative spill or positive margins. Survival between groups was similar.
There is a lack of evidence to support MIS for pediatric renal tumors. This review demonstrates that lymph node harvest has been inadequate for MIS pediatric nephrectomy and there appears to be an increased risk for intraoperative spill. Survival data are similar between groups, but follow-up times were inconsistent and patient selection was clearly biased, with only small tumors being selected for MIS.
Review article.
III.
微创肾切除术常规用于成人肾肿瘤和许多良性儿科疾病。虽然开放性根治性肾输尿管切除术仍然是 Wilms 肿瘤和大多数儿科肾恶性肿瘤的标准治疗方法,但也有越来越多的微创手术 (MIS) 用于这些手术的报道。APSA 癌症委员会进行了一项系统评价,以更好地了解 MIS 在儿科肾肿瘤患者中的风险和益处。
该搜索集中于儿童肾肿瘤的 MIS,并遵循系统评价和荟萃分析的首选报告项目 (PRISMA) 清单。最初的数据库搜索确定了 491 篇已发表的文章,经过对摘要和全文文章的逐步审查,共有 19 篇文章纳入了本综述。
有两项直接比较研究比较了开放性手术和 MIS。其余研究仅报告了微创肾切除术。在所有研究中,共有 151 名患者,其中 126 名患有 Wilms 肿瘤,10 名患有 RCC。104 名患者接受了 MIS,其中 47 名接受了开放性手术。在两项直接比较开放性手术和 MIS 的研究中,开放性手术中采集的淋巴结更多(中位数 = 2(MIS)比 5(开放性);均值 = 2.47(MIS)比 3.8(开放性))。许多非比较研究报告 Wilms 肿瘤的淋巴结采集数量为 2 个或更少。一些 MIS 患者也被注意到术中溢出或阳性边缘。组间生存率相似。
目前没有证据支持 MIS 用于儿科肾肿瘤。本综述表明,MIS 儿科肾切除术的淋巴结采集量不足,并且术中溢出的风险似乎增加。组间生存率相似,但随访时间不一致,患者选择明显存在偏差,只有小肿瘤被选择用于 MIS。
综述文章。
III 级。